Pharmacogenetics Testing in Psychiatry Market Advances as Personalized Medicine Transforms Depression Treatment
"Executive Summary Pharmacogenetics Testing in Psychiatry/Depression Market: Share, Size & Strategic Insights CAGR Value The global pharmacogenetics testing in psychiatry/depression market size was valued at USD 1.34 billion in 2024 and is expected to reach USD 2.97 billion by 2032, at a CAGR of 10.4% during the forecast period The key topics that...
0 Commentarii 0 Distribuiri 73 Views 0 previzualizare
Abistem https://abistem.com